Two Sigma Securities, LLC Agenus Inc Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $16,064 - $25,016	12,263 Added 116.94%	22,750 $36,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $15,206 - $30,936	10,487 New	10,487 $15,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $29,190 - $46,764	14,893 New	14,893 $31,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $32,401 - $48,150	-12,909 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $20,525 - $34,337	12,909 New	12,909 $31,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.